Back to results

The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies

Primary Purpose

Muscular Dystrophies

Status

Unknown status

Phase

Phase 1

Locations

Canada

Study Type

Interventional

Intervention

Far Infrared Radiation

About this trial

This is an interventional treatment trial for Muscular Dystrophies focused on measuring MYOTONIC DYSTROPHY, MYOPATHIES, Distal Myopathies, Muscular Dystrophy, Duchenne, Phosphorylase Deficiency (McArdle Disease)

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Persons with muscular dystrophies

Exclusion Criteria:

None

Sites / Locations

The Centre for Incurable Diseases

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Arm Description

Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

Outcomes

Primary Outcome Measures

Management and Cure of muscular dystrophies

Secondary Outcome Measures

Rehabilitation of people with muscular dystrophies

Full Information

NCT ID

NCT00674843

First Posted

May 6, 2008

Last Updated

August 14, 2009

Sponsor

GAAD Medical Research Institute Inc.

1. Study Identification

Unique Protocol Identification Number

NCT00674843

Brief Title

The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies

Official Title

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation to Manage or Treat Muscular Dystrophies.

Study Type

Interventional

2. Study Status

Record Verification Date

August 2009

Overall Recruitment Status

Unknown status

Study Start Date

May 2008 (undefined)

Primary Completion Date

May 2010 (Anticipated)

Study Completion Date

June 2010 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor

GAAD Medical Research Institute Inc.

4. Oversight

Data Monitoring Committee

Yes

5. Study Description

Brief Summary

The muscular dystrophies (MD) are a group of more than 30 neuromuscular disorders that are characterized by progressive skeletal muscle weakness, defects in muscle proteins and the death of muscle cells and tissue. This study will investigate the use of far infrared radiation for managing muscular dystrophies.

Detailed Description

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells. It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly cure these neuromuscular disorders.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Muscular Dystrophies

Keywords

MYOTONIC DYSTROPHY, MYOPATHIES, Distal Myopathies, Muscular Dystrophy, Duchenne, Phosphorylase Deficiency (McArdle Disease)

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 1

Interventional Study Model

Single Group Assignment

Masking

None (Open Label)

Allocation

Non-Randomized

Enrollment

4 (Actual)

8. Arms, Groups, and Interventions

Arm Title

Arm Type

Experimental

Arm Description

Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

Intervention Type

Radiation

Intervention Name(s)

Far Infrared Radiation

Intervention Description

Radiation: Far Infrared Radiation (5μm to 20μm wavelength) Far Infrared radiation for 30 to 40 minutes per treatment session.

Primary Outcome Measure Information:

Title

Management and Cure of muscular dystrophies

Time Frame

2 Years

Secondary Outcome Measure Information:

Title

Rehabilitation of people with muscular dystrophies

Time Frame

2 Years

10. Eligibility

Sex

All

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Persons with muscular dystrophies Exclusion Criteria: None

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Ken Nedd, M.D.

Organizational Affiliation

GAAD Medical Research Institute Inc.

Official's Role

Principal Investigator

Facility Information:

Facility Name

The Centre for Incurable Diseases

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M4V 1L5

Country

Canada

12. IPD Sharing Statement

Learn more about this trial

The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies

We'll reach out to this number within 24 hrs